• Tuhura Biosciences drew USD 1.5 million under its revolving credit facility with Parkview Holdings One.
• The credit facility, signed April 21, 2026, matures April 21, 2031, with total availability of up to USD 50 million.
• Proceeds are expected to fund general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-324174), on July 29, 2026, and is solely responsible for the information contained therein.